)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Sandu Pharmaceuticals
Sandu Pharmaceuticals (524703) investor relations material
Sandu Pharmaceuticals Q3 25/26 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 25/26 earnings summary6 Feb, 2026
Executive summary
Unaudited standalone financial results for the quarter and nine months ended 31st December 2025 were reviewed and approved by the Board on 6th February 2026.
Financial statements were prepared in accordance with Indian Accounting Standards (IND AS) and reviewed by statutory auditors.
Financial highlights
Revenue from operations for Q3 FY26 was ₹1,876.09 lakhs, up from ₹1,762.11 lakhs in the previous quarter and ₹1,837.29 lakhs in Q3 FY25.
Net profit for Q3 FY26 stood at ₹97.51 lakhs, compared to ₹52.43 lakhs in the previous quarter and ₹55.55 lakhs in Q3 FY25.
Total comprehensive income for Q3 FY26 was ₹114.47 lakhs, up from ₹66.31 lakhs in the previous quarter and ₹73.80 lakhs in Q3 FY25.
Earnings per share (EPS) for Q3 FY26 was ₹1.01, compared to ₹0.54 in the previous quarter and ₹0.57 in Q3 FY25.
Outlook and guidance
Management continues to evaluate performance based on revenue and operating income in the Ayurvedic Property Medicines segment.
Explain 9M profit growth despite flat revenue.
Reason for lower 9M stock-in-trade purchases?
Why did 9M current tax expense decrease?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sandu Pharmaceuticals
- Revenue and profit grew modestly; subsidiary wound up; cash reserves increased.524703
Q2 24/2519 Nov 2025 - Q1 FY25 saw revenue rise to ₹1,704.54 lakhs and a recommended dividend of ₹0.80 per share.524703Q1 24/2519 Nov 2025
- Stable financial performance with steady revenue, profit, and no new borrowings or equity changes.524703Q4 23/2419 Nov 2025
- Q2 FY26 saw higher revenue, improved profit, and robust cash flow in Ayurvedic medicines.524703Q2 25/2612 Nov 2025
- Q1 FY26 saw higher revenue and profit, with AGM and dividend record date set for September.524703Q1 25/2613 Aug 2025
- FY25 saw steady profit growth, a dividend proposal, and a shift to standalone reporting.524703Q4 24/2516 Jun 2025
- Q3 FY25 net profit more than doubled year-over-year as Sandu shifts to standalone reporting.524703Q3 24/256 Jun 2025
Next Sandu Pharmaceuticals earnings date
Q4 25/263 Jun, 2026
Sandu Pharmaceuticals
Next Sandu Pharmaceuticals earnings date
Q4 25/263 Jun, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage